原发性肝癌患者TACE术后血清HIF－1α和VEGF水平变化

doi:10.3969/j.issn.1672-5069.2017.06.042

Abstract

Liu Liang, Liu Jinsong, He Juan. Changes of serum hypoxia inducible factor-1α and vascular endothelial growth factor levels in patients with primary liver cancer before and after TACE[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(6): 781-782.

References

[1] 刘长兵,吴继锋. 胃癌中TGF-β1、HIF-1α、VEGF的表达及临床意义. 临床与实验病理学杂志,2013,29（7）:733-736.
[2] 冯超,赵剑波,陈勇,等. 原发性肝癌切除术后预防性经肝动脉介入治疗：肝动脉化疗栓塞术和化疗灌注术比较. 介入放射学杂志,2014,23（8）:679-682.
[3] 范阳华,叶敏华,吴雷,等. 人脑胶质瘤中 RSUME 的 SUMO 化与HIF-1α/VEGF 通路的相关性.西安交通大学学报（医学版）,2015,26（4）:472-478.
[4] 贾中芝,黄渊全,冯耀良,等. 原发性肝癌TACE前后血清HIF-1α、VEGF与CT灌注成像的相关性分析.中华医学杂志,2013,93（19）:1472-1475.
[5] Kim BK,Kim BR,Lee HJ,et al. Tumor-suppressive effect of a telomerase-derived peptide by inhibiting hypoxia-induced HIF-
1α-VEGF signaling axis. Biomaterials,2014,35（9）:2924-2933.
[6] 杜日昌,李宇芳,邱卫东,等.甲状腺乳头状癌中HIF-1α、VEGF、COX-2及VEGF-C表达与侵袭转移的关系.临床与实验病理学杂志,2013,29（9）:991-995.
[7] 周俭珊,叶红.HIF-1α、VEGF及HIF-1α/VEGF轴在子宫内膜癌中的表达研究进展. 海南医学,2015,32（16）:2413-2416.
[8] 罗勇,林少华,黄权,等.脑膜瘤内的血管分布和血管生成与HIF-
1α、VEGF的关系.中华神经医学杂志,2013,12（1）:68-71.
[9] Liu D,Cao G,Cen Y,et al. The radiosensitizing effect of CPG ODN107 on human glioma cells is tightly related to its antiangiogenic activity via suppression of HIF-1α/VEGF pathway. Int Immune Pharmacol,2013,17（2）:237-244.
[10] 郭勇英,位庚,李红蓉,等. 通心络联合外周血间充质干细胞移植对糖尿病足大鼠血管新生磷脂酰肌醇3激酶/蛋白激酶B信号通路的影响研究.中国全科医学,2016,19（13）:1602-1606.
[11] 张成佳,何仕诚,滕皋军,等. TACE治疗原发性肝癌对肝功能影响的相关因素分析. 东南大学学报（医学版）,2013,32（1）:18-22.
[12] 李娜. 结肠癌患者HIF-1αVEGF和MMP-9表达及临床意义.河北医学,2014,18 （1）:7-9.
[13] 冯阳阳,白雪红,海平,等. 食管鳞癌组织中HIF-1α、VEGF和EGFR的表达与放射治疗疗效的关系.实用医学杂志,2016,32（15）:2458-2461.
[14] 陈东风,孙文静. 原发性肝癌血管性介入治疗现状. 实用肝脏病杂志,2015,18（3）：225-224.

[1]	Liu Xing, Zhao Shuli, Zhang Dianlong. Effect of sevoflurane inhalation on hepatic ischemia-reperfusion injury in patients with primary liver cancer undergoing partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(5): 728-731.
[2]	Pei Ying, Huang Feng, Yin Hongzhen, et al. Preliminary study on intestinal microecology in mice with xenograft hepatoma intervened by sodiumnorcantharidate [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 486-489.
[3]	Dai Qingyun, Wang Rundong, Jia Weidong. Prediction of early tumor recurrence by predictive nutritional index in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 561-564.
[4]	Cui Faqiang, Li Tao, Wang Zheng, et al. A pilot study on cetuximab and KRAS gene mutation in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 565-568.
[5]	Yang Fucun, Shang Huaixue, Gai Yonghao. Enhanced magnetic resonance imaging by gadolinium disodium sebacate in diagnosis of patients with focal liver lesions [J]. Journal of Practical Hepatology, 2019, 22(4): 577-580.
[6]	Peng Xinjian, Xiao Yuhui, Xu Siding. Diagnostic value of diffusion-weighted magnetic resonance imaging in patients with radiation-induced liver injury with underlying hepatocelullar carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 373-376.
[7]	Zhao Xiaoguang, Shi Yujie. Protective effect of reduced glutathione on liver function in patients with advanced primary liver cancer underwent transarterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 425-428.
[8]	Li Ketian, Shen Mingge, Wang Fengrong, Hu Chunrong, Cao Yujie, Lu Peng. Impact of blood glucose levels on imaging quality of PET/CT examination in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 256-259.
[9]	Zhang Bangjian, Wei Shoucun, Yang Xiaoyan. Effects of dexmedetomidine combined with propofol anesthesia on perioperative stress response and postoperative recovery quality in patients undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 264-267.
[10]	Xu Dafeng, Zhou Kailun, Li Zhuori, et al.. Preliminary observation of miR-144 liposomes on inhibition of proliferation, migration and invasion of liver cancer cells in vitro and in vivo [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 25-28.
[11]	Li Fang, Zou Guizhou, Gao Yufeng, et al.. Frequency of PD-1 copy number variation in individuals with hepatitis B viral infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 37-40.
[12]	Wang Cuixiao, Gao Jing.. Serum Golgi protein 73, lentil lectin-reactive alpha-fetoprotein-L3,AFP andα-L- fucosidase levels in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 113-116.
[13]	Dai Xiaonan, Lyu Jinyan, Weng Wencai, et al.. Expression of IFITM3 in hepatocellular carcinoma and its correlation with intrahepatic tumor recurence after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 117-120.
[14]	Chen Xiang, Wang Baolin, Wu Chen, et al.. Efficacy of transcatheter arterial chemoembolization and radion implantation in the treatment of patients with primary liver cancer and its impact on hepatic expressions of TRF1 and TRF2 [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 121-124.
[15]	Ma Lyuxiang, Zhang Xuesong.. Efficacy and prognosis of ultrasound-guided percutaneous radiofrequency ablation in treatment of patients with small hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 125-128.

Changes of serum hypoxia inducible factor-1α and vascular endothelial growth factor levels in patients with primary liver cancer before and after TACE

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments